Condition: Friedreich Ataxia · Cardiomyopathy · Sponsor: Lexeo Therapeutics
Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)
This description comes directly from the study's public registry record.
Lexeo Clinical Trials · 212-547-9879 · clinicaltrials@lexeotx.com
Always discuss trial participation with your own doctor first.
| University of California San Diego | La Jolla, California, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Indiana University - Riley Children's Health | Indianapolis, Indiana, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Washington University School of Medicine in St. Louis | St Louis, Missouri, United States | Recruiting |
| Cincinnati Children's Hospital | Cincinnati, Ohio, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
| Hospital Universitário Walter Cantídio - Universidade Federal do Ceará | Fortaleza, Ceará, Brazil | Recruiting |
| Instituto D'or de Pesquisa e Ensino - Hospital São Rafael | Salvador, Estado de Bahia, Brazil | Recruiting |
| Hospital Das Clínicas Da Universidade Federal De Minas Gerais (UFMG) | Belo Horizonte, Minas Gerais, Brazil | Recruiting |
| Campinas State University (UNICAMP) | Campinas, São Paulo, Brazil | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06865482